GlassScriptPhysician profile
Benjamin Jacob Johnson
NPI 1982356366
$582.58
in general payments reported to CMS, 2019-2025
11 companies · $259 in 2025
The $259 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $45.59 · 2023: $138 · 2024: $140 · 2025: $259.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $537.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $536.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $126.26 | 2025 | |
| Phathom Pharmaceuticals, INC. | $125.00 | 2024 | Voquezna |
| Avita Medical Americas, LLC | $85.24 | 2023 | Recell |
| Smith+Nephew, INC. | $53.80 | 2022-2023 | Oasis, Grafix Pl |
| Haemonetics Corporation | $44.22 | 2022-2023 | Teg6s Hemostasis System |
| Medtronic, INC. | $39.15 | 2025 | Inceptiv |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $32.00 | 2025 | Caplyta |
| Lilly USA, LLC | $28.18 | 2025 | Zepbound, Mounjaro |
| Ani Pharmaceuticals, INC. | $20.01 | 2025 | Purified Cortrophin Gel |
| Dexcom, INC. | $15.12 | 2024 | Dexcom G6 Transmitter |
| Lundbeck LLC | $13.60 | 2025 | Rexulti |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Benjamin Johnson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.